Virios Therapeutics, Inc. (VIRI)
NASDAQ: VIRI · IEX Real-Time Price · USD
0.351
-0.035 (-8.96%)
At close: May 17, 2024, 3:59 PM
0.233
-0.119 (-33.78%)
After-hours: May 17, 2024, 7:59 PM EDT
Virios Therapeutics Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Virios Therapeutics.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for VIRI.
Recommendation Trends
Rating | Jul '22 | Aug '22 | Sep '22 |
---|---|---|---|
Strong Buy | 1 | 1 | 0 |
Buy | 0 | 0 | 0 |
Hold | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 |
Total | 1 | 1 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 20, 2022 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Dec 15, 2021 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.28
from -0.28
EPS Next Year
-0.31
from -0.28
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | n/a | 13.6M | 55.4M |
Avg | n/a | n/a | n/a | 13.2M | 53.8M |
Low | n/a | n/a | n/a | 12.7M | 51.7M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | 319.6% |
Avg | - | - | - | - | 307.6% |
Low | - | - | - | - | 291.6% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -0.18 | -0.29 | -0.51 |
Avg | -0.28 | -0.31 | -0.50 |
Low | -0.36 | -0.31 | -0.48 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.